Year:  2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 

PQRS Measure

#248Substance Use Disorders: Screening for Depression Among Patients with Substance Abuse or Dependence
 Report via: Claim, Registry

The following codes apply for this PQRS measure:

CPT Codes

CodeModifierPOSDescription
90801N/AN/APsychiatric diagnostic interview examination
90802N/AN/AInteractive psychiatric diagnostic interview examination using play equipment, physical devices, language interpreter, or other mechanisms of communication
90804N/AN/AIndividual psychotherapy, insight oriented, behavior modifying and/or supportive, in an office or outpatient facility, approximately 20 to 30 minutes face-to-face with the patient;
90805N/AN/AIndividual psychotherapy, insight oriented, behavior modifying and/or supportive, in an office or outpatient facility, approximately 20 to 30 minutes face-to-face with the patient; with medical evaluation and management services
90806N/AN/AIndividual psychotherapy, insight oriented, behavior modifying and/or supportive, in an office or outpatient facility, approximately 45 to 50 minutes face-to-face with the patient;
90807N/AN/AIndividual psychotherapy, insight oriented, behavior modifying and/or supportive, in an office or outpatient facility, approximately 45 to 50 minutes face-to-face with the patient; with medical evaluation and management services
90808N/AN/AIndividual psychotherapy, insight oriented, behavior modifying and/or supportive, in an office or outpatient facility, approximately 75 to 80 minutes face-to-face with the patient;
90809N/AN/AIndividual psychotherapy, insight oriented, behavior modifying and/or supportive, in an office or outpatient facility, approximately 75 to 80 minutes face-to-face with the patient; with medical evaluation and management services
90810N/AN/AIndividual psychotherapy, interactive, using play equipment, physical devices, language interpreter, or other mechanisms of non-verbal communication, in an office or outpatient facility, approximately 20 to 30 minutes face-to-face with the patient;
90811N/AN/AIndividual psychotherapy, interactive, using play equipment, physical devices, language interpreter, or other mechanisms of non-verbal communication, in an office or outpatient facility, approximately 20 to 30 minutes face-to-face with the patient; with medical evaluation and management services
90812N/AN/AIndividual psychotherapy, interactive, using play equipment, physical devices, language interpreter, or other mechanisms of non-verbal communication, in an office or outpatient facility, approximately 45 to 50 minutes face-to-face with the patient;
90813N/AN/AIndividual psychotherapy, interactive, using play equipment, physical devices, language interpreter, or other mechanisms of non-verbal communication, in an office or outpatient facility, approximately 45 to 50 minutes face-to-face with the patient; with medical evaluation and management services
90814N/AN/AIndividual psychotherapy, interactive, using play equipment, physical devices, language interpreter, or other mechanisms of non-verbal communication, in an office or outpatient facility, approximately 75 to 80 minutes face-to-face with the patient;
90815N/AN/AIndividual psychotherapy, interactive, using play equipment, physical devices, language interpreter, or other mechanisms of non-verbal communication, in an office or outpatient facility, approximately 75 to 80 minutes face-to-face with the patient; with medical evaluation and management services
90845N/AN/APsychoanalysis
90862N/AN/APharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy
96150N/AN/AHealth and behavior assessment (eg, health-focused clinical interview, behavioral observations, psychophysiological monitoring, health-oriented questionnaires), each 15 minutes face-to-face with the patient; initial assessment
96152N/AN/AHealth and behavior intervention, each 15 minutes, face-to-face; individual
99201N/AN/AOffice or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self limited or minor. Typically, 10 minutes are spent face-to-face with the patient and/or family.
99202N/AN/AOffice or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and straightforward medical decision making. When using total time on the date of the encounter for code selection, 15 minutes must be met or exceeded.
99203N/AN/AOffice or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and low level of medical decision making. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.
99204N/AN/AOffice or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and moderate level of medical decision making. When using total time on the date of the encounter for code selection, 45 minutes must be met or exceeded.
99205N/AN/AOffice or other outpatient visit for the evaluation and management of a new patient, which requires a medically appropriate history and/or examination and high level of medical decision making. When using total time on the date of the encounter for code selection, 60 minutes must be met or exceeded.
99212N/AN/AOffice or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and straightforward medical decision making. When using total time on the date of the encounter for code selection, 10 minutes must be met or exceeded.
99213N/AN/AOffice or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and low level of medical decision making. When using total time on the date of the encounter for code selection, 20 minutes must be met or exceeded.
99214N/AN/AOffice or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and moderate level of medical decision making. When using total time on the date of the encounter for code selection, 30 minutes must be met or exceeded.
99215N/AN/AOffice or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and high level of medical decision making. When using total time on the date of the encounter for code selection, 40 minutes must be met or exceeded.
1220F1P N/APatient screened for depression (SUD)
1220F8PN/APatient screened for depression (SUD)
1220FN/AN/APatient screened for depression (SUD)
1220F8PN/APatient screened for depression (SUD)
1220FN/AN/APatient screened for depression (SUD)

ICD9 Codes

CodeModifierPOSDescription
303.90N/AN/AOther and unspecified alcohol dependence, unspecified
303.91N/AN/AOther and unspecified alcohol dependence, continuous
303.92N/AN/AOther and unspecified alcohol dependence, episodic
304.00N/AN/AOpioid type dependence, unspecified
304.01N/AN/AOpioid type dependence, continuous
304.02N/AN/AOpioid type dependence, episodic
304.10N/AN/ASedative, hypnotic or anxiolytic dependence, unspecified
304.11N/AN/ASedative, hypnotic or anxiolytic dependence, continuous
304.12N/AN/ASedative, hypnotic or anxiolytic dependence, episodic
304.20N/AN/ACocaine dependence, unspecified
304.21N/AN/ACocaine dependence, continuous
304.22N/AN/ACocaine dependence, episodic
304.30N/AN/ACannabis dependence, unspecified
304.31N/AN/ACannabis dependence, continuous
304.32N/AN/ACannabis dependence, episodic
304.40N/AN/AAmphetamine and other psychostimulant dependence, unspecified
304.41N/AN/AAmphetamine and other psychostimulant dependence, continuous
304.42N/AN/AAmphetamine and other psychostimulant dependence, episodic
304.50N/AN/AHallucinogen dependence, unspecified
304.51N/AN/AHallucinogen dependence, continuous
304.52N/AN/AHallucinogen dependence, episodic
304.60N/AN/AOther specified drug dependence, unspecified
304.61N/AN/AOther specified drug dependence, continuous
304.62N/AN/AOther specified drug dependence, episodic
304.70N/AN/ACombinations of opioid type drug with any other drug dependence, unspecified
304.71N/AN/ACombinations of opioid type drug with any other drug dependence, continuous
304.72N/AN/ACombinations of opioid type drug with any other drug dependence, episodic
304.80N/AN/ACombinations of drug dependence excluding opioid type drug, unspecified
304.81N/AN/ACombinations of drug dependence excluding opioid type drug, continuous
304.82N/AN/ACombinations of drug dependence excluding opioid type drug, episodic
304.90N/AN/AUnspecified drug dependence, unspecified
304.91N/AN/AUnspecified drug dependence, continuous
304.92N/AN/AUnspecified drug dependence, episodic
305.00N/AN/AAlcohol abuse, unspecified
305.01N/AN/AAlcohol abuse, continuous
305.02N/AN/AAlcohol abuse, episodic
305.20N/AN/ACannabis abuse, unspecified
305.21N/AN/ACannabis abuse, continuous
305.22N/AN/ACannabis abuse, episodic
305.30N/AN/AHallucinogen abuse, unspecified
305.31N/AN/AHallucinogen abuse, continuous
305.32N/AN/AHallucinogen abuse, episodic
305.40N/AN/ASedative, hypnotic or anxiolytic abuse, unspecified
305.41N/AN/ASedative, hypnotic or anxiolytic abuse, continuous
305.42N/AN/ASedative, hypnotic or anxiolytic abuse, episodic
305.50N/AN/AOpioid abuse, unspecified
305.51N/AN/AOpioid abuse, continuous
305.52N/AN/AOpioid abuse, episodic
305.60N/AN/ACocaine abuse, unspecified
305.61N/AN/ACocaine abuse, continuous
305.62N/AN/ACocaine abuse, episodic
305.70N/AN/AAmphetamine or related acting sympathomimetic abuse, unspecified
305.71N/AN/AAmphetamine or related acting sympathomimetic abuse, continuous
305.72N/AN/AAmphetamine or related acting sympathomimetic abuse, episodic
305.80N/AN/AAntidepressant type abuse, unspecified
305.81N/AN/AAntidepressant type abuse, continuous
305.82N/AN/AAntidepressant type abuse, episodic
305.90N/AN/AOther, mixed, or unspecified drug abuse, unspecified
305.91N/AN/AOther, mixed, or unspecified drug abuse, continuous
305.92N/AN/AOther, mixed, or unspecified drug abuse, episodic
Legend:
ClaimThis measure can be submitted via claim. Use the 'Data Collection' pdf associated with the measure.
GroupThis measure can be submitted through one or more groups. Click on the group name to view the group information.
RegistryThis measure can be submitted through registry.
EHRThis measure can be submitted via Electronic Health Record (EHR).
GPRO IThis measure can be submitted via Group Practice Reporting Option 1.
GPRO IIThis measure can be submitted via Group Practice Reporting Option 2.

More information on these alternative reporting mechanisms is available at:
    http://www.cms.gov/PQRS/20_AlternativeReportingMechanisms.asp.
demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.